| Erin L Heinzen | Duke University School of Medicine (R.S.D., NC Institute for Genomic Medicine (E.L.H., Columbia University, The University of Melbourne, Austin Health and Royal Melbourne Hospital, Australia Centre for Clinical Translation (M.R.J.), Imperial College London, Charing Cross Hospital Campus, The Florey Institute of Neuroscience |
| Michael R Johnson | Duke University School of Medicine (R.S.D., NC Institute for Genomic Medicine (E.L.H., Columbia University, The University of Melbourne, Austin Health and Royal Melbourne Hospital, Australia Centre for Clinical Translation (M.R.J.), Imperial College London, Charing Cross Hospital Campus, The Florey Institute of Neuroscience |
| David B Goldstein | Duke University School of Medicine (R.S.D., NC Institute for Genomic Medicine (E.L.H., Columbia University, The University of Melbourne, Austin Health and Royal Melbourne Hospital, Australia Centre for Clinical Translation (M.R.J.), Imperial College London, Charing Cross Hospital Campus, The Florey Institute of Neuroscience |
| David B Goldstein | Duke University School of Medicine (R.S.D., NC Institute for Genomic Medicine (E.L.H., Columbia University, The University of Melbourne, Austin Health and Royal Melbourne Hospital, Australia Centre for Clinical Translation (M.R.J.), Imperial College London, Charing Cross Hospital Campus, The Florey Institute of Neuroscience |